JAMF vs WST · rev $627.4M vs P/E 35, rev $2.89B
Jamf Holding (JAMF) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Jamf Holding (JAMF) is a software - application company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported JAMF revenue for 2024-12-31 was $627.4M. Net income was -$68.5M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. JAMF currently screens at market cap $1.25B.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
JAMF currently screens at market cap $1.25B. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the JAMF and WST stock pages for the full models.
Not investment advice.